Webinar Dec. 14: How to Encourage Latinos to Participate in Clinical Trials


Take Action
Share On Social!

Latinos represent 18.5% of the U.S. population, but are far less than 10% of those in federal cancer and drug studies.

This makes it hard for researchers to create treatments that work best for Latinos.

To address this issue, you’re invited to join us for How to Encourage Latinos to Participate in Clinical Trials,” the first webinar of a new series, “Let’s Address Health Equity Together,” at 11 a.m. CST on Dec. 14, 2021.

This Zoom webinar will help health care professionals understand the lack of Latino participation in clinical trials and explore strategies and system-changing advocacy actions to improve Latino enrollment in clinical trials.

“This webinar will help doctors, nurses, researchers and other healthcare professionals take action for diversifying clinical trials in South Texas and beyond,” said Dr. Amelie Ramirez, leader of Salud America! at UT Health San Antonio, who is the moderator for the webinar.


Learn about the Webinar Panelists on Latinos and Clinical Trials

On Dec. 14, 2021, panelists Dr. Patricia Chalela, Dr. Marcella Mazo-Canola, and Jeraldine Ortiz, will present on ways to increase Latino participation in clinical trials, with a discussion and question-and-answer session moderated by Dr. Amelie Ramirez.

Dr. Amelie G. Ramirez, an internationally recognized researcher in Latino health promotion and behavioral change, is director of Salud America! and its home base, the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio. She has spent over 30 years directing research on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos, including cancer risk factors, clinical trial recruitment, tobacco prevention, obesity prevention, and promotion of health equity. She also is associate director of cancer outreach and engagement at the NCI-designated Mays Cancer Center at UT Health San Antonio.

Dr. Patricia Chalela is an associate professor at the Institute for Health Promotion Research at UT Health San Antonio. Her work and expertise are in social and behavioral sciences, health communications, and promotion and health disparities research. Read more about her at salud.to/chalela.

Dr. Marcela Mazo Canola is a physician and assistant professor specializing in breast oncology and hematology at the Mays Cancer Center of UT Health San Antonio. Her research focus is on solid tumors malignancies in the Latino population as well as the different health disparities that affect the community.

Jeraldine Ortiz is a breast cancer survivor and clinical trial participant. When she was diagnosed over 15 years ago, her doctor encouraged Jeraldine to volunteer for a breast cancer clinical trial at the Mays Cancer Center at UT Health San Antonio. Now she encourages other Latinas to participate in clinical trials. Read more about her at salud.to/Ortiz.


Behind the Webinar Series on Health Equity

The “Let’s Address Health Equity Together” webinar series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

Salud America! is a national Latino-focused organization that creates culturally relevant and research-based stories, videos, and tools to inspire people to start and support healthy changes to policies, systems, and environments where Latino children and families can equitably live, learn, work, and play.

The Mays Cancer Center, also known as the UT Health San Antonio MD Anderson Cancer Center, has a mission to decrease the burden of cancer in San Antonio, South Texas and beyond. We bring South Texas a level of exceptional care that is comparable with the nation’s most respected programs. More patients put their trust in our program because we have a unique understanding of our community’s cancer care needs. We excel in delivering advanced therapies.

Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at gene.com.


Explore More:

Cancer, Clinical Trials

By The Numbers By The Numbers



Expected rise in Latino cancer cases in coming years

Share your thoughts